FIRVANQ

Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 19 Mar 2025)

What this means for you

Registered since 08 Jan 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Jan 2029: the §8 & §9 renewal).

Record

Serial number
87715534
Registration number
5651067
Mark type
Design + words
Filed
11 Dec 2017
Published for opposition
24 Apr 2018
Registered
08 Jan 2019
Next maintenance filing
§8 & §9 renewal, due by 08 Jan 2029 (grace period to 08 Jul 2029)
Attorney of record
Douglas R. Wolf

Goods and services

  • Class 005 — Pharmaceuticals: antibiotics; pharmaceutical preparations, namely, vancomycin for the treatment of colitis and gastrointestinal disorders in oral solution form, powder form and diluent form; pharmaceutical preparations, namely, vancomycin for the treatment of clostridium difficile and staphylococcus aureus colitis in oral solution form, powder form and diluent form

Owner

Prosecution history

  • 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
  • 19 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 19 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 19 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 22 Nov 2024 — TEAS SECTION 8 & 15 RECEIVED
  • 08 Jan 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 29 Apr 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 23 May 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 23 May 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 26 Mar 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 26 Mar 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 08 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
  • 04 Dec 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 03 Dec 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 27 Nov 2018 — STATEMENT OF USE PROCESSING COMPLETE

View this trademark record on Rightsy